The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that the U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results